| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/10/2009 | EP2066683A1 Derivatives of 5-thioxylopyranose and use of same for treatment |
| 06/10/2009 | EP2066680A1 Triphenylphosphonium thionitrite nitric oxide donors |
| 06/10/2009 | EP2066666A1 Pyrazolopyridine, indazole, imidazopyridine, imidazopyrimidine, pyrazolopyrazine and pyrazolopyridine derivates as stimulators of guanylate cyclase for cardiovascular disorders |
| 06/10/2009 | EP2066649A1 Process for the preparation of amorphous and crystalline forms of candesartan cilexetil using column chromatography |
| 06/10/2009 | EP2066635A2 2-phenoxy nicotine acid derivative and use thereof |
| 06/10/2009 | EP2066619A2 Soluble epoxide hydrolase inhibitors |
| 06/10/2009 | EP2066337A2 Use of exendins, exendin agonists and glp-1 receptor agonists for altering the concentration of fibrinogen |
| 06/10/2009 | EP2066324A2 Cycloalkanopyrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
| 06/10/2009 | EP1383869B1 Progenitor cell populations, expansion thereof, and growth of non-hematopoietic cell types and tissues therefrom |
| 06/10/2009 | EP1319003B1 Xanthine phosphodiesterase v inhibitors |
| 06/10/2009 | EP1115421B1 Use of glp-1 or analogs in treatment of stroke |
| 06/10/2009 | CN101450934A Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 06/10/2009 | CN101450057A Use of oxicam compounds |
| 06/10/2009 | CN100497598C Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 06/10/2009 | CN100497388C Antibody selective for tumor necrosis factor-related apoptosis-inducing ligand receptor and use thereof |
| 06/10/2009 | CN100497340C Condensed purine derivatives as A1 adenosine receptor antagonists |
| 06/10/2009 | CN100497334C Indole derivatives useful as histamine h3 antagonists |
| 06/10/2009 | CN100497323C New heterocyclic oxime compounds, preparing process and medical composition thereof |
| 06/10/2009 | CN100497314C Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them |
| 06/10/2009 | CN100497313C New isoquinoline compounds, their preparation method and medicine composition containing them |
| 06/10/2009 | CN100497302C Diarylurea derivatives and their use as chloride channel blockers |
| 06/10/2009 | CN100496563C Combination of natural products for curing hyperlipemia, atherosclerosis and relevant disease |
| 06/10/2009 | CN100496510C Injection for necrotizing therapy for hemorrhoids |
| 06/10/2009 | CN100496495C Remedies and/or preventives for diabetic ischemic heart diseases |
| 06/09/2009 | US7544859 for introducing DNA into organisms which produce large amounts of oils; genetic engineering; for animal feed, foods, cosmetics and pharmaceuticals; kits |
| 06/09/2009 | US7544853 C1 inhibitor with short half-life transient treatment |
| 06/09/2009 | US7544839 N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide; nervous system disorders; melatoninergic system disorders; industrial synthesis |
| 06/09/2009 | US7544835 Carboxylic acid derivative and salt thereof |
| 06/09/2009 | US7544812 For example, 2-(4-{2-[1-(4-tert-Butyl-benzyl)-3-methyl-2-oxo-imidazolidin-4-yl]-ethoxy}-2-methyl-phenoxy)-2-methyl-propionic acid, 2-(4-{3-[1-(4-tert-Butyl-benzyl)-3-methyl-2-oxo-imidazolidin-4-yl]-propyl}-2-methyl-phenoky)-2-methyl-propionic acid; for treating diabetes mellitus |
| 06/09/2009 | US7544799 Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
| 06/09/2009 | US7544790 Nucleotide sequences coding heavy chain of immunoglobulin specific for human tissue factor for use in prevention and treatment of thrombosis |
| 06/09/2009 | US7544788 Isolated nucleic acid molecule encoding a neurotrophic growth factor |
| 06/09/2009 | US7544711 Cyclooxygenase inhibitors; musculoskeletal and cardiovascular disorders; antiinflammatory agents |
| 06/09/2009 | US7544703 N-(3,5-Dimethylphenyl)-2-[2-(4-methylpiperazin-1-yl)pyridin-4-ylmethylthio]pyridine-3-carboxamide; 2-(2-Cyclopropylaminopyridin-4-ylmethylthio)-N-(3,5-dimethylphenyl)pyridine-3-carboxamide; cancer, rheumatoid arthritis, age-related macular degeneration, diabetic retinopathy, retinopathy of prematurity |
| 06/09/2009 | US7544700 4-chloro-N-((5-((4-(hexylamino)piperidin-1-yl)sulfonyl)thien-2 -yl)methyl)benzamide for example; JUN kinase inhibitors to treat nervous system disorders, cancer, cardiovascular and autoimmune disorders |
| 06/09/2009 | US7544689 (2S3R)-3-{9-Isopropyl-6-[(pyridin-2-ylmethyl)-amino]-9H-purin-2-ylamino}-pentan-2-ol; treating proliferative disorders, viral disorders, CNS disorders, diabetes, stroke, alopecia or neurodegenerative; cancer, leukemia, psoriasis; cyclin-dependent kinase (CDK) inhibitors |
| 06/09/2009 | US7544684 Hydrazono-malonitriles |
| 06/09/2009 | US7544678 Anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) |
| 06/09/2009 | US7544655 Novel amino acid sequences are within the carboxy termini of fibrinogen; useful for cell culture and cell separation |
| 06/09/2009 | US7544497 Modulating sirtuin deacetylase protein; apoptosis; using flavone, stilbene, isoflavone, sphingosine; stroke; cardiovascular disorders; antiarthritic agents; Alzheimer's disease |
| 06/09/2009 | US7544480 drug screening an antagonist which inhibits hydroxylation of hypoxia inducible factor or an agonist which promotes hydroxylation of hypoxia inducible factor; hydroxylation of asparagine; antitumor agent; use for radiotherapy or chemotherapy |
| 06/09/2009 | US7544359 Antiischemic agents; anticholesterol agents; cardiovascular disorders |
| 06/09/2009 | CA2519432C Pharmaceutical compositions comprising cetp inhibitors and a water-insoluble concentration-enhancing additive for the treatment of cardiovascular disease |
| 06/09/2009 | CA2438141C Noninvasive measurements of chemical substances |
| 06/09/2009 | CA2371554C Pharmaceutical composition comprising an angiotensin ii antagonist for preventing, treating or development-inhibiting simple retinopathy and preproliferative retinopathy |
| 06/09/2009 | CA2355720C New substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines |
| 06/09/2009 | CA2269083C Novel fgf homologs |
| 06/04/2009 | WO2009070378A1 Compositions and methods for inhibiting the activation of dsrna-dependent protein kinase and tumor growth inhibition |
| 06/04/2009 | WO2009070241A2 Angiotensin ii receptor antagonists |
| 06/04/2009 | WO2009070130A1 The 1,3-disubstituted ureas, method of re aration and utilisation thereof |
| 06/04/2009 | WO2009069736A1 Nitrogenated compound |
| 06/04/2009 | WO2009069610A1 Fused indane compound |
| 06/04/2009 | WO2009069546A1 Therapeutic or prophylactic agent, detection method and detection agent for metabolic syndrome, and method for screening of candidate compound for therapeutic agent for metabolic syndrome |
| 06/04/2009 | WO2009069291A1 Prophylactic and/or therapeutic composition for disease caused by inhalation of tobacco smoke |
| 06/04/2009 | WO2009069100A1 Phosphonic acid derivates and their use as p2y12 receptor antagonists |
| 06/04/2009 | WO2009068911A1 Compositions and methods for reducing macrovascular complications in diabetic patients |
| 06/04/2009 | WO2009068557A1 Novel phenyl-acetamide and phenyl-propionamide derivatives useful as potassium channel modulators |
| 06/04/2009 | WO2009068509A1 Novel benzamide derivatives useful as potassium channel modulators |
| 06/04/2009 | WO2009068177A1 DERIVATIVES OF 4-(2-AMINO-1 -HYDROXYETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR |
| 06/04/2009 | WO2009045309A3 Use of v2 receptor antagonists in combination with vasopressinergic agonists |
| 06/04/2009 | WO2009040022A3 Use of a peptide as a therapeutic agent |
| 06/04/2009 | WO2009035927A3 Bis-cyclyl substituted ureas or amides as soluble epoxide hydrolase inhibitors |
| 06/04/2009 | WO2009034470A3 Future cardiac event biomarkers |
| 06/04/2009 | WO2009033815A3 Use of the peptide combination ala-pro-gly-pro-arg with cecropin a as a therapeutic agent |
| 06/04/2009 | WO2009033734A3 Use of a peptide as a therapeutic agent |
| 06/04/2009 | WO2009033657A3 Use of trp6-triptorelin and d-leu6-leuprolide as therapeutic agents |
| 06/04/2009 | WO2009027753A4 Composition and method inhibiting inflammation |
| 06/04/2009 | WO2009016514A3 1, 3 and 1, 3, 5 substituted imidazoles as antihypertensiva |
| 06/04/2009 | WO2008156817A3 Renin inhibitors |
| 06/04/2009 | WO2008147245A3 Controlled release proxodolol pharmaceutical composition |
| 06/04/2009 | US20090143469 Salts of nateglinide |
| 06/04/2009 | US20090143455 Pyrazoles Useful in the Treatment of Inflammation |
| 06/04/2009 | US20090143434 Methods of using domperidone to terminate acute episodes of cardiac arrhythmia, to restore normal sinus rhythm or heart rate, to prevent recurrence of cardiac arrhythmia and to maintain normal sinus rhythm or heart rate in mammals |
| 06/04/2009 | US20090143426 Synthesis of 1,3,6-trisubstituted-2-carboxyquinol-4-ones as selective ET A antagonists and their use as medicaments |
| 06/04/2009 | US20090143386 Human adam-10 inhibitors |
| 06/04/2009 | US20090143375 Tricyclic Lactam Derivatives, Their Manufacture and Use as Pharmaceutical Agents |
| 06/04/2009 | US20090143372 Chemical compounds |
| 06/04/2009 | US20090143365 Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors |
| 06/04/2009 | US20090143358 Inhibitors of ion channels |
| 06/04/2009 | US20090143319 Transcription factor decoy |
| 06/04/2009 | US20090143300 Treatment of sepsis and septic shock using ghrelin and growth hormone |
| 06/04/2009 | US20090143296 Methods and compositions for the repair and/or regeneration of damaged myocardium |
| 06/04/2009 | US20090143294 Administering a sub-constricting amount of calyculin A and a vasoconstrictor where the sub-constricting amount is sufficient to restore blood vessel sensitivity to the vasoconstrictor and does not cause contraction of the blood vessel itself; antishock agents; a myosin light chain phosphatase inhibitor |
| 06/04/2009 | US20090143279 Methods and compositions for treating metabolic disorders |
| 06/04/2009 | US20090142831 Placental stem cells |
| 06/04/2009 | US20090142401 Multiparticulates comprising low-solubility drugs and carriers that result in rapid drug release |
| 06/04/2009 | US20090142351 Human and rat PGC-3, PPAR-gamma coactivations and splice variants thereof |
| 06/04/2009 | US20090142339 Humanized Anti-CCR2 Antibodies and Methods of Use Therefor |
| 06/04/2009 | US20090142329 Interleukin-1 Beta Converting Enzyme Like Apoptosis Protease-3 and 4 |
| 06/04/2009 | US20090142312 Methods for Promoting Wound Healing and Muscle Regeneration with the Cell Signaling Protein Nell1 |
| 06/04/2009 | US20090142306 Methods and systems for treating ischemic tissues |
| 06/04/2009 | US20090142297 5-substituted isoindoline compounds |
| 06/04/2009 | US20090142296 Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue |
| 06/04/2009 | US20090142295 Anti-Connexin Compounds and Uses Thereof |
| 06/04/2009 | CA2706656A1 Compositions and methods for inhibiting the activation of dsrna-dependent protein kinase and tumor growth inhibition |
| 06/04/2009 | CA2706475A1 Phosphonic acid derivates and their use as p2y12 receptor antagonists |
| 06/04/2009 | CA2706333A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the .beta.2 adrenergic receptor |
| 06/04/2009 | CA2706171A1 Fused indane compound |
| 06/04/2009 | CA2705262A1 Angiotensin ii receptor antagonists |
| 06/03/2009 | EP2065401A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |